TARA · Protara Therapeutics, Inc.

$3.85 -0.05 (-1.28%) At close · Aug 21

Market Cap

$229.29M

59.10M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jesse Shefferman	President, Chief Executive Officer and Director	$654,888	—	$294,450	$1,277,216	$351,184	$78,036	$2,655,774
Leonardo Nicacio	Chief Medical Officer	$373,864	$75,000	$208,500	$453,435	$229,753	$41,931	$1,382,483
Jacqueline Zummo	Chief R&D Officer	$494,000	—	$110,985	$481,844	$219,521	$75,924	$1,382,274

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jesse Shefferman	President, Chief Executive Officer and Director	$632,342	—	$112,690	$542,604	$432,919	$71,288	$1,791,843
Jacqueline Zummo	Chief Scientific Operations Officer	$475,755	$150,000	$43,930	$208,226	$266,119	$70,159	$1,214,189
Jathin Bandari	Former Chief Medical Officer	$135,378	$150,000	$43,930	$208,226	—	$543,742	$1,081,276
Patrick Fabbio	Chief Financial Officer	$464,967	—	$42,020	$199,107	$260,325	$57,117	$1,023,536

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jesse Shefferman	President, Chief Executive Officer and Director	$607,882	—	$154,926	$736,124	$341,351	$65,849	$1,906,132
Patrick Fabbio	Chief Financial Officer	$412,875	$25,000	—	$746,910	$206,758	$51,986	$1,443,529
Jacqueline Zummo	Chief Scientific Operations Officer	$432,446	—	$60,098	$285,592	$200,625	$61,087	$1,039,848

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jesse Shefferman	President, Chief Executive Officer and Director	$587,622	—	$291,870	$1,377,367	$460,103	$63,934	$2,780,896
Blaine Davis	Former Chief Financial Officer	$228,667	—	$97,290	$460,752	—	$599,549	$1,386,258
Jacqueline Zummo	Chief Scientific Operations Officer	$417,835	—	$97,290	$460,752	$264,150	$61,691	$1,301,718
Jathin Bandari	Chief Medical Officer	$414,475	—	$84,645	$400,448	$259,956	$13,430	$1,172,954

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jesse Shefferman	President, Chief Executive Officer and Director	$569,987	—	—	$3,111,830	$328,020	$58,824	$4,068,661
Jacqueline Zummo	Chief Scientific Operations Officer	$405,444	—	—	$1,155,383	$169,290	$56,961	$1,787,078
Blaine Davis	Former Chief Financial Officer	$409,303	—	—	$1,155,383	$170,837	$14,483	$1,750,006

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jesse Shefferman	President, Chief Executive Officer and Director	$506,681	—	$1,500,000	$4,999,542	$694,463	$54,692	$7,755,378
Blaine Davis	Chief Financial Officer	$343,367	—	—	$2,791,556	$236,390	$12,289	$3,383,602
Julio Casoy	Former Chief Medical Officer	$234,054	—	$1,365,000	—	$115,500	$464,144	$2,179,698
Jacqueline Zummo	Chief Scientific Operations Officer	$324,927	—	$1,365,000	—	$269,919	$31,335	$1,991,181

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Timothy Noyes	Former President, Chief Executive Officer and Director	$411,347	—	—	$710,045	—	$561,218	$1,682,610
George Eldridge	Former Chief Financial Officer	$377,278	—	—	$288,028	$151,124	$445,288	$1,261,718
Steven Burke	Former Chief Medical Officer	$261,966	—	—	$288,028	—	$452,720	$1,002,714
Julio Casoy	Former Chief Medical Officer	$348,504	—	—	$255,920	—	$18,067	$622,491
Jesse Shefferman	President, Chief Executive Officer and Director	$343,621	—	—	—	—	$35,455	$379,076
Jacqueline Zummo	Ph.D., MPH, MBA Chief Scientific Operations Officer	$289,425	—	—	$47,065	—	$17,162	$353,652
Blaine Davis	Chief Financial Officer	—	—	—	—	—	—	—

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Timothy Noyes	Former President, Chief Executive Officer and Director	$531,914	—	—	$829,200	$265,957	$3,875	$1,630,946
Steven Burke	Former Chief Medical Officer	$434,948	—	—	$439,380	$173,979	$4,904	$1,053,212
George Eldridge	Former Chief Financial Officer	$365,034	—	—	$439,380	$142,363	$2,291	$949,068
Jacqueline Zummo	Ph.D., MPH, MBA Senior Vice President, Research Operations	$185,158	$56,250	—	$192,515	—	$16,781	$450,704
Jesse Shefferman	President, Chief Executive Officer and Director	$268,049	—	—	—	—	$32,771	$300,820
Julio Casoy	Chief Medical Officer	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Leonardo Viana Nicacio, M.D.	Chief Medical Officer	Resigned	2026-06-26	2026-06-29
Jathin Bandari, M.D.	Chief Medical Officer	Resigned	2024-04-11	2024-03-18
Patrick Fabbio	Chief Financial Officer	Appointed	2023-01-30	2023-01-30
Hannah Fry	Controller	Appointed	2022-07-16	2022-07-18
Blaine Davis	Chief Financial Officer	Resigned	2022-07-15	2022-06-21
Jathin Bandari, M.D.	Chief Medical Officer	Appointed	2022-01-10	2022-01-10
Jathin Bandari, M.D.	VP, Head of Clinical Development and Interim Chief Medical Officer	Appointed	2021-10-15	2021-10-18
Jane Huang, M.D.	Class I director	Appointed	2021-06-09	2021-06-10
Martín Sebastian Olivo	Chief Medical Officer	Appointed	2021-04-19	2021-04-19
Cynthia Smith	Class III director	Appointed	2021-01-29	2021-02-02
Jacqueline Zummo, Ph.D., MPH, MBA	Chief Scientific Operations Officer	Appointed	2021-01-01	2020-12-07
Richard Levy, M.D.	Audit Committee member	Appointed	2020-07-23	2020-07-24
Barry Flannelly, Pharm.D, MBA	Class III director	Appointed	2020-07-23	2020-07-24
Scott Braunstein, M.D.	Board of Directors	Resigned	2020-07-20	2020-07-24

Key facts CIK 1359931 CUSIP 74365U107 13F (30d) 112 filings 112 filers Visit website Investor relations